Skip to content

ENDUROMED

Active
Private limited companyfounded 200719 yrs activeHoutstraat 1, 9800 Deinze, BelgiumKBO/BCE: BE 0888.032.030

ENDUROMED has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €430k and a net result of €219k. Equity is growing by ~69.6% per year across the filed fiscal years. Its solvency ranks better than 63% of 57 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
93 / 100
Excellent▲ +7 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency98▲+49
Growth52▼-26
Stability100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 1.92 against 1.01 in 2024), and 32.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
67.2%
Return on assets
34.3%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 19 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-08-2026, 25 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
25 d late
2024
29 d late
2023
26 d late
2022
29 d late
2021
30 d late
2020
31 d late
2019
61 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
04-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€430k▲ 104%
2024 · €210k
2023: €137k 2024: €210k
2023 → 2025
Total assets
€639k▼ 5.1%
2024 · €673k
2023: €527k 2024: €673k
2023 → 2025
Net result
€219k▼ 19.8%
2024 · €273k
2023: €222k 2024: €273k
2023 → 2025
Working capital
€194k▲ 3,414%
2024 · €6k
2023: €41k 2024: €6k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€137k-€210k▲ 53.5%€430k▲ 104%
Operating result€286k-€342k▲ 19.6%€287k▼ 16.2%
Net result€222k-€273k▲ 23.1%€219k▼ 19.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2023: €286k€286kNet result 2023: €222k€222kOperating result 2024: €342k€342kNet result 2024: €273k€273kOperating result 2025: €287k€287kNet result 2025: €219k€219k202320242025
The operating result falls in 2025; 2025 is 16% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €639k
Fixed assets €236k▲ 15.2%
Current assets €403k▼ 13.9%
Equity and liabilities €639k
Equity €430k▲ 104%
Debt €210k▼ 54.7%
The debt ratio falls from 68.8% to 32.8%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€312k
2024 · €362k
Cash flow
€244k
2024 · €294k
Solvency
67.2%
2024 · 31.2%
Current ratio
1.92
2024 · 1.01
Quick ratio
1.92
2024 · 1.01
Debt / equity
0.49
2024 · 2.20
ROE
51.0%
2024 · 130.0%
ROA
34.3%
2024 · 40.6%
Interest coverage
2926.67
2024 · 419.20
Debt
€210k
2024 · €463k
Debt ≤ 1 year
€210k
2024 · €463k
Income taxes
€68k
2024 · €90k
Staff costs
€17k
2024 · €19k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Total assets 20/58€673k€639k
Fixed assets 21/28€205k€236k
Formation expenses 20€0€0=
Tangible fixed assets 22/27€205k€236k
Financial fixed assets 28-€250
Current assets 29/58€468k€403k
Amounts receivable within one year 40/41€415k€367k
Cash & bank 54/58€53k€36k
Total equity & liabilities 10/49€673k€639k
Equity 10/15€210k€430k
Contributions / capital 10/11€7k€7k=
Reserves 13€130k€130k=
Accumulated profits (losses) 14€73k€293k
Amounts payable 17/49€463k€210k
Amounts payable within one year 42/48€463k€210k
Trade debts payable within one year 44€9k€3k
Income statement Code20242025
Gross operating margin 9900€386k€330k
Operating result 9901€342k€287k
Financial income 75€22k€601
Financial charges 65€865€106
Result before taxes 9903€363k€287k
Income taxes 67/77€90k€68k
Net result for the period 9904€273k€219k
Result to be appropriated 9905€273k€219k

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
25-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 25 days late
2025
31-12
Financial Weakest financial yearnet €219k ▼19.8%
Net result drops to €219k, the lowest in the series.
29-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial Highest result since 2023net €273k ▲23.1%
Operating result €342k, net result €273k, both a record.
31-12
Financial Equity above €200kEq €210k ▲53.5%
2 profitable years in a row build equity to €210k.
26-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 26 days late
2023
29-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
30-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
08-08
State Gazette act Registered-office change
2021
31-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
30-09
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 61 days late
2019
31-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 31 days late
2018
31-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
31-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 31 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 5 acts read
About the unread acts

Of the 5 Belgian State Gazette acts we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Comparable companies · same sector, comparable size

Similar companies · same sector, comparable size

Of 1,176 companies in sector 72109 we hold annual accounts for 691. 485 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded16-03-2007
Fiscal year end31-12
Activities, NACEBEL
72109Other research and development on natural sciences
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesBelgian Official Gazette · 1 actNational Bank · 18 filingsAddress and cadastre registers

Data from official sources, last processed on 13-08-2026. Scores and ratios are computed by Checked and are not a credit decision.